Clinical R&D intelligence

Technology partners for clinical trials & drug development

Better decisions, fewer handoffs and less manual work across clinical development. Backed by PrecisionAI technology.

Every decision starts with better evidence.

The context

Drug development depends on thousands of experts.Help them focus on work that matters.

The value they create is in judgment. Protecting expert time is becoming as strategic as protecting the science itself.

As portfolios grow and decision cycles shorten, organisations that act with clarity will pull ahead—not because they have more data, but because they use expertise more deliberately.

Edian works alongside your team to make that possible.

“At the end of phase two, eight functions each traditionally get two slides. The head of R&D has to decide from that. This is a hugely pivotal decision. The results that follow from those decisions will impact board-level metrics.”
Top-5 Pharma VP Oncology

Trust & confidence

Trusted partners for modern medicine.

We’ve spent a decade building AI systems for some of the world’s most highly regulated environments, where transparency, traceability and human oversight are essential. Edian gives your team decision alpha - unique tooling that supports fast, accurate decisions & deliverables.

GxP-aligned, 21 CFR Part 11, Data safe in your environment.

For better:

  • Sponsor, CRO & Vendor Collaboration
  • Clinical Trial Planning & Ops
  • Regulatory Intelligence
  • Quality and Manufacture
  • Commercial & Market Access
  • Medical Affairs

Designed together

Co-design the future of your organisation.

For complex needs, we work with you to design the organisation that you need to achieve your mid-term goals, then deliver incremental production-ready solutions in as little as two weeks.

Every solution is shaped around your people, your workflows and the way your teams already work, making adoption easy and ensuring changes lead to real results.

Backed by

  • Venrex
  • 8VC
  • Form Ventures
  • Kima Ventures
  • Pareto
  • Circle & Co.
  • Tiny Supercomputer
  • Combination
  • Better Angle

$3m raised.

Plus scouts from Sequoia, Andreessen Horowitz, Index Ventures and Octopus Ventures.

Case study

Empowering 2000 national staffing decisions per week.

For teams with global impact

Empower the labs

The next generation of labs are producing increasingly effective molecules.

Yet thousands of programs each year are paused due to high perceived cost, risk and decision bandwidth.

Equipping decision committees with data-rich go/no-go intelligence unlocks the next generation of drug candidates.

Prepare for pandemics

Pandemics take the lives of as many as 100,000 people a week. Every day we reduce the risk of the next event is counted in real lives saved.

Your investments in clinical operations and pandemic preparedness projects help the world respond to epidemics before they escalate.

Build for the waiting patient

Contrary to popular conception, regulators often spend longer waiting for data from life science companies than the other way around.

Your time-to-market work can accelerate development programs by weeks or even months, and means patients get access to effective care sooner, without rushing professional review or safe evidence collection.

For biological problem solvers

Your team has embraced the hardest challenge in life science - evidence, translation & production. You get to support the next cohort of cheap, abundant therapies & reduce the global burden of disease.

Talk to us about your toughest problems and how we can help.

“We once lost a contract because a competitor included a project management plan that wasn’t even asked for. We answered every question correctly and still lost. Our new approach is to go above and beyond, bringing forward much of the study-start work into proposal planning.”
Head of commercial at a full-service CRO

Get started

Welcome to a new era for modern medicine

Download the case study

Enter your email and the PDF will download straight away.